• Information for health professionals conferences

Allergen immunotherapy in Australia and New Zealand

Suppliers of allergen immunotherapy products

Stallergenes Greer
Suppliers of Stallergenes Greer, Hollister Stier, Albey* and Hymenoptera* products *see information below regarding current availability of these products
Supliers of TGA registered Actair, Albey, Hymenoptera and Oralair 
PO Box 281 Mona Vale NSW 1660 Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Phone: 1800 824 166 (AU) 

Seqirus (a CSL Company)

Suppliers of TGA registered Acarizax and Grazax  
63 Poplar Road Parkville VIC 3052 Australia
Phone: 1800 008 275 (AU)

AMSL Allergy

Suppliers of Inmunotek and ALK-Abello products
2 McCabe Place Chatswood NSW 2067 Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 02 9882 3666 (AU) 
 
Gamma Allergy 
 
Gold Coast, QLD, Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 
Phone: 1300 881 405 (AU)

Ferrer Pharma Pty Ltd

Suppliers of Lofarma, Diater (including antibiotic and venom allergens) and Chemotechnique patch test products
4 Pinehurst Ave, Rouse Hill, NSW 2155
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: 1300 022 789

Bee venom immunotherapy update

Shortage of venom immunotherapy products: honey bee, paper wasp and yellow jacket - supply update from Stallergenes Greer

13 April 2018

As communicated in March 2018, events overseas have impacted the ability of Stallergenes Greer to supply venom immunotherapy products to Australia and New Zealand.  The first direct shipment of venom products from JHS to Australia has now arrived, and ASCIA has recieved the following advice:

Honey Bee venom

• Hymenoptera Honey Bee venom will be available again in Australia towards the end of week commencing 16 April 2018.

Please note: only orders for the “Hymenoptera” brand of honey bee venom will be processed at this time. Customers with backorders for the “Albey” brand honey bee venom are advised to contact their wholesaler and request these orders be changed to “Hymenoptera” or cancelled as appropriate. For any assistance, contact the Stallergenes Greer Customer Service team on 1800 824 166 or email This email address is being protected from spambots. You need JavaScript enabled to view it.

• In New Zealand there is sufficient Albey Honey Bee venom stock to meet demand over the next 6 months.

Paper Wasp venom

• Paper Wasp venom is currently out of stock in Australia. Stallergenes Greer is  endeavouring to confirm the date of the next available shipment of Paper Wasp venom and will provide updates as soon as possible.

• In NZ there is sufficient Albey Paper Wasp venom stock to meet demand over the next 3 months.

Yellow Jacket venom

• Yellow Jacket venom is NOT out of stock in either Australia or New Zealand, however the remaining Albey Yellow Jacket venom stock is short-dated (expiry May 2018). Hymenoptera Yellow Jacket venom will be available from May 2018.

For any further assistance, please contact Stallergenes Greer according to the information set out below:

• For orders or status of orders, please contact the Customer Service team on 1800 824 166 or email This email address is being protected from spambots. You need JavaScript enabled to view it. 
• For medical information enquiries, please contact Dr Martin Rees (APAC Regional Medical Director) on This email address is being protected from spambots. You need JavaScript enabled to view it.  
• To report adverse events, please contact Stallergenes Greer on 1800 824 166

Stallergenes Greer understands the impact of this shortage on both patients and prescribers, and are committed to ensuring reliable supply of these important products into Australia and New Zealand on an ongoing basis.

Further updates will be provided to the ASCIA community as soon as more information is available.

2 March 2018

Stallergenes Greer has recently received information affecting supply of all venom immunotherapy products to Australia and New Zealand, including Honey Bee venom, Paper Wasp venom and Yellow Jacket venom.  This change in circumstances is due to news about a shutdown of ALK manufacturing facilities in the US. 

This has required JHS (supplier of venom immunotherapy to Stallergenes Greer) to reprioritise the supply of venom immunotherapy products to meet additional demands in the US on an ongoing basis.  On receiving this news, Stallergenes Greer has made immediate arrangements with JHS to secure stock of all three products directly from the US.

The current stock situation in Australia and New Zealand is as follows: 

Honey Bee venom

  • In Australia Honey Bee venom is currently out of stock. Hymenoptera Honey Bee venom is expected to be available again in Australia in around mid-April 2018.
  • In New Zealand there is sufficient Albey Honey Bee venom stock to meet demand over the next 6 months.

Paper Wasp venom

  • in Australia Paper Wasp venom is currently out of stock. Stallergenes Greer will confirm the date of the next available shipment as soon as possible.
  • In New Zealand there is sufficient Albey Paper Wasp venom stock to meet demand over the next 3 months.

Yellow Jacket venom

  • Yellow Jacket venom is NOT out of stock in either Australia or New Zealand. 
  • However the remaining Albey Yellow Jacket venom stock is short-dated (expiry May 2018).
  • Stallergenes Greer will confirm the date of the next available shipment as soon as possible.

For guidance on how to make decisions about the appropriate care for patients currently receiving venom immunotherapy, and measures to avoid interruptions to therapy in high-risk patients, you may wish to refer to the:

For any further assistance, please contact Stallergenes Greer as follows:

  • For orders or status of orders, please contact the Customer Service team on 1800 824 166 or by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.
  • For medical information enquiries, please contact Dr Martin Rees (APAC Regional Medical Director) by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.  
  • To report adverse events, please contact Stallergenes Greer on 1800 824 166

Stallergenes Greer understands the impact of this shortage on both patients and prescribers, and are committed to ensuring reliable supply of these important products into Australia and New Zealand on an ongoing basis.

Further updates will be sent to ASCIA members as soon as more information is available.

8 December 2017 

Further to previous communications regarding the supply of Hymenoptera Honey Bee venom extract (see below) this product can now be accessed via the regular wholesaler channel.
 
Wholesalers now have the product in stock, and can accept orders immediately. The ordering details are: 

Supplier Code
 

Brand Name
 

Pack description
 

Unit
 

Unit Price
 

PBS Code
 

PBS Reimbursement Effective
 

6781PG
 

Hymenoptera Honey Bee Venom 550µg injection kit
 

One pack of freeze-dried powder of Honey Bee venom + one 9mL vial of diluent
 

Each
 

$233.39
 

10621B
 

1 July 2017
 


For any questions or support regarding this issue, please call our customer service team on 1800 824 166.  

Hymenoptera honey bee venom freeze-dried powder has been authorised for supply under S19A (1), of the Therapeutic Goods Act as an alternative for Australian patients

14 June 2017

Following the previous communication in early 2007 from Stallergenes Greer regarding the shortage of ALBEY honey bee venom 550mcg, the US/Canadian approved 550mcg-concentrated Hymenoptera honey bee venom freeze-dried powder has been authorised for supply under S19A (1), of the Therapeutic Goods Act as an alternative for Australian patients.

Therefore Hymenoptera 550mcg honey bee venom product can now be prescribed as an alternative option for ALBEY honey bee Venom 550mcg.

The same PBS code 10621B will apply, which was previously used for Hymenoptera honey bee venom. PBS reimbursement will be effective from 1st July 2017. Any prescription written before 1st July will not be eligible for PBS subsidy.

All prescriptions must state the product name “Hymenoptera honey bee venom”. It is recommended to add the PBS code 10621B to aid product identification.

In order to meet special requirements under the TGA, each vial of Hymenoptera honey bee venom 550mcg supplied to a patient must include a vial of Albumin Saline diluent. The items will be supplied as listed below:

1 carton containing Hymenoptera honey bee venom 550mcg with US product information
1 clear resealable plastic bag containing 1 x 9 mL vial Albumin Saline diluent (AUST R 32486) attached to 1 copy of ALBEY product information
2 important letters of communication for your attention

The shortage of ALBEY honey bee venom and therefore the above information does not apply to New Zealand.

Content updated April 2018 

Disclaimer and Privacy

The ASCIA website is intended for use by ASCIA members, other health professionals, the general public and media. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors and Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites.

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the
HONcode standard for
trustworthy health
 information.

Verify here.